Metal chelating heteroaryl small molecules have found widespread use as building blocks for coordination-driven, self-assembling nanostructures. The metal chelating non-canonical amino acid ((2,2′-bipyridin-5yl)alanine (Bpy-Ala) could in principle be used to nucleate specific metalloprotein assemblies if introduced into proteins such that one assembly had much lower free energy than all alternatives. Here we describe the use of the Rosetta computational methodology to design a self-assembling homo-trimeric protein with [Fe(Bpy-ala)3] 2+ complexes at the interface between monomers. X-ray crystallographic analysis of the homotrimer showed that the design process had near atomic level accuracy: the all atom RMSD between the design model and crystal structure for the residues at the protein interface is ~1.4 Å These results
demonstrate that computational protein design together with genetically encoded non-canonical amino acids can be used to drive formation of precisely specified metal-mediated protein assemblies that could find use in a wide range of photo-physical applications.
Significance:
This article reports the computational design of a 3-fold symmetric, self-assembling protein homotrimer containing a highly stable non-canonical amino acid mediated metal complex within the protein interface. To achieve this result, recently developed protein-protein interface design methods were extended to include a metal chelating non-canonical amino acid containing a bipyridine functional group in the design process. Bipyridine metal complexes can give rise to photochemical properties that would be impossible to achieve with naturally occurring amino acids alone and suggests that the methods reported here could be used to generate novel photoactive proteins.
Introduction:
2,2'-bipyridine (Bpy) is one of the most widely used metal ligands in inorganic chemistry due to its redox stability, ability to form high affinity complexes of defined geometry with a variety of transition metals, and useful photochemical properties (1). The highly specific geometries adopted by Bpy in metal complexes has led to its widespread use in generating coordination-driven self-assembling nanostructures (2) . For example, chemically synthesized, unstructured peptides containing the Bpy functional group as the side chain of an amino acid formed three helix bundles upon addition of metals (3, 4) . Recently, the ability to use Bpy in biological contexts was expanded through the addition of the non-canonical amino acid (NCAA) (2,2'-bipyridin-5yl)alanine, (Bpy-ala) to the genome of Escherichia coli (5) . Because Bpy forms very stable octahedral complexes with a number of biologically relevant divalent cations (e.g.
Fe 2+ , Zn 2+ , Co 2+ , and Ni 2+ ), an appropriately placed Bpy-ala residue could potentially be utilized to generate self-assembling proteins nucleated by [M(Bpy)3] 2+ complexes (where M is a divalent cation that forms an octahedral complex with Bpy). Although we (6) and others (7, 8) have engineered proteins in which Bpy-ala served in structural or functional capacities, to our knowledge the possibility of using this NCAA to drive or stabilize the formation of a protein complex has not been explored.
The strategy of using metal ions to mediate protein complex formation has its origins in naturally occurring proteins such as hexameric proinsulin in which complex formation is regulated by bound Ca 2+ and Zn 2+ ions (9) . Recently, the Tezcan (10) and Kuhlman (11) groups used rational and computational protein design methods, respectively, to engineer metaldependent protein-protein interactions using conserved di-histidine metal binding motifs from known metalloproteins. In each case, structural analysis of the engineered protein complexes suggested that although metal dependent assembly had been achieved, the metal binding sites had not formed as desired (10, 11) . While notable successes, these studies highlight the difficulty in precisely stabilizing the conformations of multiple amino acid side chains at once.
We reasoned that an appropriately placed, genetically encoded Bpy-ala residue could nucleate a 3-fold symmetric, homo-trimeric metalloprotein while overcoming some of the difficulties faced in the previous studies.
Here we report the use of the Rosetta computational protein design methodology (12) to engineer a homo-trimeric protein containing an octahedral [Fe(Bpy-ala)3] 2+ complex.
Crystallographic analysis indicated that near atomic level accuracy between the design model and resulting protein was achieved in the vicinity of the protein-protein interface. The methods developed in this study could be applied to the generation of novel protein therapeutics, protein based materials, and metalloproteins with useful optical or photochemical properties.
Results

Computational design strategy
A previous study in which Bpy-ala was used to engineer a novel metal binding site in a protein scaffold highlighted important considerations for protein design efforts using this NCAA (6) . In a design in which the Bpy-ala residue was not well constrained by packing interactions, we observed the formation of a highly stable [Fe(Bpy-alaf)2(Bpy-alap)] 2+ complex (where Bpyalaf is the free amino acid in the cell, and Bpy-alap is NCAA which has been incorporated in the protein) within the E. coli expression host. This observation was encouraging from the perspective that protein containing [Fe(Bpy-ala)3] 2+ complexes can be purified intact from E. coli, but also suggested that for the present application, mono-or dimeric forms of the desired trimeric protein could be kinetically trapped by free Bpy-ala within the cell. Furthermore, even if a [Fe(Bpy-alap)3] 2+ complex is formed as desired, in the absence of a driving force other than the Bpy-ala complex formation, the subunit orientations in the resulting protein complexes would not likely be well defined.
To address these concerns, our computational design approach sought to achieve two distinct goals: identification of sites of Bpy-ala incorporation in starting scaffolds that are compatible with trimer formation, and design of interactions between protein subunits to drive the formation of a particular trimeric orientation at the exclusion of others. Our starting scaffold set consisted of a set of 9 de novo designed repeat proteins of known structure recently reported by our lab (13, 14) . Because they are constructed from many identical subunits, the sizes of repeat proteins can be easily scaled in a defined manner and the versatility in length afforded by repeat protein architectures could be useful for downstream applications.
Potential sites of Bpy-ala incorporation within a given starting scaffold were first identified using Rosetta docking calculations (see supplemental information for full computational design methods). For each parent scaffold, 3 rotational and 1 translational degrees of freedom were sampled with a 2.5° covering radius to generate all possible 3-fold symmetric conformations in the context of polyalanine versions of the parent scaffolds. Successfully docked proteins contained geometrically complementary interfaces without steric clashes between the protein backbones of adjacent subunits.
We next searched for potential sites of octahedral [M(Bpy-ala)3] 2+ complex incorporation within these trimeric scaffolds. Because previous results indicated that [Fe(Bpy-ala)3] 2+ complexes can form within E. coli expression hosts (6), we chose to design our trimeric proteins in the context of these complexes. Octahedral Bpy complexes exist in two enantiomeric forms,  and  and geometric constraints for each isomer were extracted from the Cambridge Structural Database (CSD ID KICRAR), and used to generate a [Fe(Bpy-ala)3] 2+ complex with ideal geometries for further calculations (Fig. 1A ). All symmetry related C atoms in a given docked configuration were then computationally scanned for the ability to overlap with the Cs in and -Bpy-ala complexes. Placed Bpy-ala complexes were removed from further consideration if the C-C-C angle differed by more than 3° from the value of 116° observed in the crystal structure of a Bpy-ala containing protein (PDB ID 4iww).
Docked trimer models containing a [Fe(Bpy-ala)3] 2+ complex ( Fig. 1B) were then subjected to iterative rounds of RosettaDesign (15) to generate a low energy, well-packed interface between protein subunits (Fig. 1C ). These designs were then filtered on the shape complementarity (16) between protein interfaces and the change in solvent exposed surface area (SASA) upon dissociation of the protein complex. (18) . Both TRI_03 and TRI_05 had as their parent scaffolds de novo designed ankyrin like repeat proteins (PDB IDs 4gpm and 4hb5 respectively) (13) . Purified designs were then subjected to analysis by size exclusion chromatography (SEC), and were observed to elute at volumes indicative of proteins slightly larger than expected for the trimeric complexes relative to standards of known molecular weight ( Fig. 2B and 2D ). This discrepancy in apparent size could be due to the unusually large Stokes radii of the trimeric complexes (19) . Although both proteins formed some soluble aggregates ( Fig. 2B and 2D ), TRI_03 appeared to be more prone to aggregation than TRI_05. Chiral  and  Bpy complexes give rise to characteristic circular dichroism (CD) signals in the near UV. CD analysis of TRI_05 gave a spectrum characteristic of the  isomer ( Fig. 2E) (18) , which was consistent with the designed complex.
Initial Characterization of the Designed Proteins
To further characterize TRI_03 and TRI_05, the proteins were expressed and purified in large scale in preparation for crystallographic analysis. TRI_03 was observed to precipitate at high protein concentration, likely due to its propensity to aggregate. In contrast, TRI_05 was stable at high concentrations, and was subjected to crystallographic trials.
Structural Characterization of TRI_05
We solved the structure of TRI_05 to 2. 
Transient Absorbance Analysis of TRI_05
Femtosecond time resolved spectroscopic methods can be used to probe the photophysical properties of complexes such as [Fe(Bpy)3] 2+ (20) . Photoexcitation of such complexes in the MLCT domain results in the transfer of an electron from the metal ion to the ligands and the solvent environment can affect the evolution of the excited state (21) . Because TRI_05 represents the first example of a protein containing a [Fe(Bpy-ala)3] 2+ complex, we explored the possibility that the excited state dynamics would be altered by encapsulation of the complex within the protein environment. We therefore carried out femtosecond time resolved absorption spectroscopy on both TRI_05 and the free [Fe(Bpy-ala)3] 2+ complex. Excitation at 440 nm results in a characteristic loss of absorbance (bleaching) in the MLCT range (450-700 nm, Fig. 4A ). Recovery of this bleach was used to determine excited state decay. Overlays of the excited state decays measured at 530 nm (corresponding to the wavelength with largest A) of TRI_05 and the free [Fe(Bpy-ala)3] 2+ complex are essentially superimposable (Fig. 4B ). To more fully quantify any differences, mono-exponential fits of these data were carried out, and suggested lifetimes of 690 ps for TRI_05 and 610 ps for the free complex (Fig. S2 ). These TRI_05 is that the [Fe(Bpy-ala)3] 2+ complex is only partially buried within the protein interface, and is solvent accessible from at least one face ( Fig. 3 A and B) . Additionally, the solvent- 
Metal Dependence of the Complex
TRI_05 was purified from the expression host in complex with Fe 2+ . In order to analyze the dependence of the protein complex the bound metal, we attempted to remove the metal from the protein by adding an excess of the potent chelator 1,10-phenanthroline (Phen), which has an affinity for Fe 2+ ~4 orders of magnitude higher than Bpy (22) . Incubation of TRI_05 with an excess of Phen at 25 °C did not result in rapid exchange of the two metal ligands. We reasoned that metal removal might be accelerated at increased temperatures, and thus examined the thermal stability of TRI_05 using CD analysis ( Fig. S3A-D) . Although slight unfolding was observed with increasing temperatures (Fig. S3B ), TRI_05 did not appear to fully denature up to 95 °C (Fig. S3C ). Furthermore, the partial unfolding was found to be reversible upon cooling to room temperature (Fig. S3C ). TRI_05 was incubated with an excess of Phen for 1 hour at 65 °C, after which spectroscopic analysis indicated the presence of a [Fe(Phen)3] 2+ complex, with no discernable signal indicative of [Fe(Bpy)3] 2+ complex ( Fig. S4 A and B) . TRI_05 was then again subjected to SEC to remove unbound Phen and the [Fe(Phen)3] 2+ complex. Apo TRI_05 eluted from the SEC column at the same volume observed prior to metal removal ( Fig. S4 C) , suggesting the presence of Fe 2+ was not required to maintain the trimeric complex. Eluted TRI_05 was analyzed spectroscopically at high concentration and no signal in the range of 450-575 nm was observed suggesting the bound Fe 2+ had been removed (Fig. S4 D) . The possibility existed that apo TRI_05 scavenged metal, most likely Zn 2+ during the purification process. To examine this, we carried out inductively coupled plasma mass spectrometric (ICP-MS) analysis of purified TRI_05 before and after removal of Fe 2+ with Phen (Table S1 ). Although very little Zn 2+ was observed in the Fe 2+ containing trimer, a 2:1 ratio of Zn 2+ to Fe 2+ was observed in the apo protein suggesting the protein may have bound to Zn 2+ during the purification process. To further confirm that a bound metal ion was not required for complex formation, we co-transformed the plasmid encoding the TRI_05 gene with a plasmid containing a synthetase that suppresses the amber stop codon with tyrosine rather than Bipy-ala. This tyrosine containing protein was subjected to SEC analysis and was observed to elute at the same time as the metal containing TRI_05 suggesting the presence of bound metal is not required to maintain trimer formation ( Fig. S4 E) . Finally, we explored the possibility that apo TRI_05 associated in a concentration dependent manner. When apo TRI_05 was subjected to SEC at 750 µM, the protein eluted at a volume consistent with the previously observed trimer with a shoulder indicative of a higher order species. When diluted to 75 µM and 35 µM, apo TRI_05 eluted at volumes 1.4 and 2 mL later than the concentrated sample respectively (Fig. S4 F) . This suggests that, in the absence of a bound metal ion, TRI_05 is capable of self-associating, but does so in a concentration dependent fashion.
We then examined the ability to re-form the [Fe(Bpy-ala)3] 2+ complex through addition of Fe 2+ to solutions of apo TRI_05. Ferrous ammonium sulfate was added to a final concentration of 20 µM to a solution of apo TRI_05 at 60 µM and incubated for 12 hours at 65 °C for 1 hour. Spectroscopic analysis of the TRI_05 suggested that no re-metallation had occurred under these conditions. We hypothesized that this was due to formation of a metal free complex in which one or more Bipy-ala side chains were buried in the protein interface. We then diluted apo TRI_05 to a final concentration of 2.5 µM (below the concentration observed to elute as a monomer on SEC) and concentrated the protein in the presence of 10 µM ferrous ammonium sulfate via ultrafiltration. The concentrated protein had an absorbance spectrum consistent with the original TRI_05 ( Fig. S4 G) , and analysis by SEC suggested that the complex had partially reformed whereas apo TRI_05 subjected to the same conditions in the absence of Fe 2+ remained a monomer (Fig. S4 H) .
Discussion
From the perspective of design of functional metalloproteins, the use of the Bpy functional group in a biological context provides a number of advantages. The Bpy ligand provides two pyridyl nitrogens in an orientation compatible with metal binding, and therefore has a higher inherent metal affinity than any naturally occurring amino acid. Bpy is also neutral and non-polar and hence it should be compatible with protein interfaces comprised mostly of hydrophobic residues. The energies of formation of octahedral complexes of Bpy with biologically relevant metals range from -18.0 kcal / mol for Zn 2+ to -27.5 kcal / mol for Ni 2+ (values calculated from affinities reported in (22) ) rivaling those of the tightest known proteinprotein interactions (23) . However, one potential drawback to the use of Bpy-ala in this manner is that these energetically favorable complexes form very rapidly and do not readily exchange at neutral pH (24) . Thus, while genetically encoded Bpy-ala could potentially be used to nucleate a C-3 symmetric, heterotrimeric protein complex around a bound metal, the potential to kinetically trap the protein complex as a monomer or dimer with free Bpy-ala, or form complexes with unintended orientations must be avoided.
We addressed these issues by using the Rosetta computational protein design methodology to identify sites of Bpy-ala incorporation in protein scaffolds of known structure that were sterically compatible with complex formation and to design novel protein-protein interfaces that provide an additional driving force for the formation of the desired complexes at the exclusion of other, undesired states. Of the seven computationally designed proteins we characterized experimentally, two were observed to have spectroscopic signatures indicative of the formation of [Fe(Bpy-ala)3] 2+ complexes. Determination of the structure of one of these designs, TRI_05, revealed a trimeric metalloprotein containing the desired [Fe(Bpy-ala)3] 2+ complex; high similarity between the solved structure and the design model was observed in the vicinity of the trimeric interface. Removal of the bound Fe 2+ ion from TRI_05 with the potent metal chelator 1,10-phenanthroline did not result in the dissolution of the trimeric protein complex into its component monomers (Fig. S4 C) . This result highlights the ability of computational protein interface design algorithms to engineer high affinity interfaces between proteins that can be used to drive the formation of complexes of desired orientations. 
Materials and Methods
Generation and cloning of designed proteins
Sequences of the designed proteins were backtranslated and optimized for expression in E. coli using DNAWorks (26) . DNAWorks also generates sets of overlapping oligonucleotides from which full-length genes can be generated through assembly PCR (26) . These oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA) and assembled through a two-step PCR reaction. PCR assembled gene fragments were then cloned into a pET21 expression vector (Novogen) between NdeI and XhoI restriction sites. Sequences of the full-length genes were confirmed by Sanger sequencing.
Protein expression and purification
Slightly different protocols were used for analytical and production scale protein expressions. Detailed descriptions of each of these methods can be found in the SI; a general protein expression and purification protocol follows. Sequence confirmed pET21 expression plasmids were co-transformed with the pEVOL-BpyRS plasmid into chemically competent BL21(DE3) cells (Life Technologies) and were selected on LB-agar plates containing ampicillin and chloramphenicol antibiotics. Colonies with resistance to both antibiotics were used to inoculate expression cultures in Terrific Broth (TB) supplemented with both antibiotics.
Expression cultures were grown at 37 °C until an optical density at 600 nm (OD600) value of ~0.75 was reached. The temperature was dropped to 18 °C and the Bpy-ala NCAA was added to a final concentration of 150 µM. Expression was induced through the addition of L-arabinose and isopropyl -D-1-thiogalactopyranoside to final concentrations of 0.02% and 1 mM respectively and growth was allowed to continue at 18 °C for 30 hours at which time cells were harvested via centrifugation.
Cell pellets were lysed via sonic dismembration and the lysates were clarified by centrifugation. The designed proteins were then purified by immobilized metal ion affinity chromatography on Ni-NTA resin (Qiagen) followed by SEC analysis on a Superdex 75 column (G.E. Biosciences). The SEC step served to further purify the protein and also indicated the size of the expressed proteins.
Crystallization of TRI_05
TRI_05 was dialyzed against 25 mM Tris buffer pH 8.0 containing 150 mM NaCl, and concentrated via centrifugal ultrafiltration to a final concentration of 12 mg / ml. Concentrated TRI_05 was screened using the sparse matrix method (27) 
Metal removal from TRI_05
TRI_05 at concentrations between 50 and 75 µM, and in buffer containing 50 mM Tris, pH 7.6 and 150 mM NaCl was directly mixed with 1,10-phenanthroline to give a final chelator concentration of 1 mM. The protein and 1,10-phenanthroline mixture was then incubated at 65 °C for one hour. To separate TRI_05 from free 1,10-phenanthroline and the [Fe(Phen)3] 2+ complex generated during the incubation, the mixture was subjected to gel filtration immediately after the incubation was complete.
Re-addition of Fe 2+ to TRI_05
Apo TRI_05 was diluted to a concentration of 2.5 µM in buffer containing 50 mM Tris, pH 7.6 and 150 mM NaCl from which contaminating metals had been removed by treatment with Chelex 100 resin. Ferrous ammonium sulfate was added to the protein solution to a final concentration of 10 µM and the mixture was applied to a Vivaspin 20 centrifugal concentrator (Sartorius). The protein was concentrated via centrifugation at 4,500 x g to a final volume of 0.5 mL and was immediately subjected to analysis by SEC.
ICP-MS analysis of proteins
To prepare samples for ICP-MS analysis, TRI_05 bound to Fe 2+ and apo TRI_05 were dialyzed extensively against 1.5 L of 50 mM Tris, pH 7.6, and 150 mM NaCl. In total, the buffer was changed 5 times. Prior to dialysis, beakers were soaked overnight in 2 mM EDTA in an effort to remove contaminating metals. Buffers were also treated with Chelex 100 (Biorad) resin to remove exogenous metals. Samples were digested for three hours in trace metal grade HNO3 and H2O2 with heating. After drying, samples were further digested overnight in concentrated HNO3 and HCl, and again were dried. Dilute HNO3 was added to a final volume of 15 mL the samples were applied to the instrument. Analysis was carried out on an iCAP Q quadrupole Electron X-series ICP-MS instrument (Thermo) in kinetic energy discrimination mode.
X-ray diffraction collection and structural solution of TRI_05
X-ray diffraction data were obtained at the Advanced Light Source on beamlines 8.21 at wavelength 1.0 Å, and the initial data were processed with HKL2000 (28). Phase information was obtained with molecular replacement using PHASER (29); a single chain of the TRI_05 design in which all side chains were truncated at C was used as a search model. Side chains were modeled using AutoBuild (30) using the sequence of the designed protein in which Bpy-ala was mutated to alanine. Bpy-ala was substituted for alanine in the AutoBuild generated model using PyMol (31) . The model containing Bpy-ala was used as an input for a round of Rosetta-Phenix refinement (32) , after which iterative rounds of structural refinement (including addition of water molecules) were carried out with PHENIX (33) .
Transient Absorption Studies
For transient absorption (TA) studies, 50 femtosecond laser pulses were generated by a where broadband, visible probe light was generated at a sapphire plate. TA spectra were collected in random order at 300 log-spaced time delays over the interval of ~2 ps to 5 ns; spectra at each time point were averaged over three scans. Data were processed with Surface Explorer software (Ultrafast Systems), and plotted and fit to single exponential decays using Computational interface design methods were used to engineer highly complementary surfaces between trimer subunits (light blue sticks) to drive the formation of a protein complex with a desired 3-fold symmetric orientation. 
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